Atlas Trials

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Clinical trial NCT04636632 · COMPLETED

Trial details

NCT number
NCT04636632
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2020-11-24
Primary completion
2022-11-04
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.